Product

Short-course regimen

1 clinical trial

1 indication

Indication
Tuberculosis
Clinical trial
Clinical Efficacy of a Short-course Regimen for Subclinical Tuberculosis in China
Status: Active (not recruiting), Estimated PCD: 2025-10-01